$OMDA

Gracey Craig sold $37K of OMDA

Gracey Craig (Chief Accounting Officer) sold 2,083 shares of Omada Health, Inc. (OMDA) at $18.00 on 2026-06-22 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Gracey Craig
Published Jun 24, 2026, 8:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 8:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$OMDA
Neutral
high confidence
Mentioned
$OMDA
Relevance
2/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$OMDANeutralLow
01

Why it matters

This disclosure updates the insider-trading record but does not indicate a new fundamental catalyst (no guidance, deal, litigation, or regulatory action).

02

Market read

Traders may log the sale for sentiment/positioning, but it is unlikely to drive a standalone repricing.

03

What to watch

The sale size and 10b5-1 structure reduce interpretability; without additional context (e.g., multiple concurrent sales, option exercises, or earnings proximity), signal quality is low.

Relevance 2/10Novelty 3/10Timing: Filed 2026-06-24 after-hours; reflects sale executed 2026-06-22.

Background

SEC Form 4 reports an insider transaction by Omada Health’s Chief Accounting Officer, Gracey Craig, executed under a pre-arranged Rule 10b5-1 plan.

Company-level read

Ticker impact

$OMDANeutralHigh confidence
Context

Omada Health CFO Gracey Craig sold 2,083 shares in an open-market transaction at $18.00 on 2026-06-22 under a 10b5-1 plan.

Expected impact

Minimal near-term impact; any effect is likely noise unless paired with other disclosures.

Evidence & confidence

The filing is a Form 4 insider transaction with a pre-arranged 10b5-1 plan and a relatively small dollar amount versus typical OMDA trading/market cap.

Market effects

No clear sector read-through; this is company-specific insider liquidity rather than operational/regulatory change.

None.

None.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can coincide with private concerns; traders may watch for clustering of sales around specific events.

Key entities

  • Omada Health, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • Gracey Craig

    Chief Accounting Officer who sold shares under a 10b5-1 plan.

Related articles

$OMDAHigh

Omada Health, Inc. (OMDA): Results of Operations and Financial Condition

Omada Health, Inc. (OMDA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99 2 q2fy26pressrelease.htm EX-99 Document Omada Health Reports Second Quarter 2026 Results and Announces CEO Transition • Revenue Grew 43% and Total Members Increased 45% Year over Year, with Gross Margin Reaching a New Quarterly Record • Company Announces Sean Duffy to Becom